Gene expression analysis in myotonic dystrophy: Indications for a common molecular pathogenic pathway in DM1 and DM2

Annalisa Botta, Laura Vallo, Fabrizio Rinaldi, Emanuela Bonifazi, Francesca Amati, Michela Biancolella, Stefano Gambardella, Enzo Mancinelli, Corrado Angelini, Giovanni Meola, Giuseppe Novelli

Research output: Contribution to journalArticle

Abstract

An RNA gain-of-function of expanded transcripts is the most accredited molecular mechanism for myotonic dystrophy type 1 (DM1) and 2 (DM2). To disclose molecular parallels and divergences in pathogenesis of both disorders, we compared the expression profile of muscle biopsies from DM1 and DM2 patients to controls. DM muscle tissues showed a reduction in the major skeletal muscle chloride channel (CLCN1) and transcription factor Sp1 transcript levels and an abnormal processing of the CLCN1 and insulin receptor (IR) pre-mRNAs. No essential differences were observed in the muscle blind-like gene (MBNL1) and CUG binding protein 1 (CUGBP1) transcript levels as well as in the splicing pattern of the myotubularin-related 1 (MTMR1) gene. Macroarray analysis of 96 neuroscience-related genes revealed a considerable similar expression profile between the DM samples, reflective of a common muscle pathology origin. Using a twofold threshold, we found six misregulated genes important in calcium and potassium metabolism and in mitochondrial functions. Our results indicate that the DM1 and DM2 overlapping clinical phenotypes may derive from a common trans acting mechanism that traps and influences shared genes and proteins.

Original languageEnglish
Pages (from-to)339-351
Number of pages13
JournalGene Expression
Volume13
Issue number6
DOIs
Publication statusPublished - 2007

Fingerprint

Myotonic Dystrophy
Gene Expression
Muscles
Genes
Sp1 Transcription Factor
Chloride Channels
RNA Precursors
Insulin Receptor
Neurosciences
Potassium
Carrier Proteins
Skeletal Muscle
RNA
Pathology
Calcium
Phenotype
Biopsy
Proteins

Keywords

  • Expression analysis
  • Ion channels
  • Myotonic dystrophy
  • Pathogenesis
  • Splicing

ASJC Scopus subject areas

  • Genetics

Cite this

Botta, A., Vallo, L., Rinaldi, F., Bonifazi, E., Amati, F., Biancolella, M., ... Novelli, G. (2007). Gene expression analysis in myotonic dystrophy: Indications for a common molecular pathogenic pathway in DM1 and DM2. Gene Expression, 13(6), 339-351. https://doi.org/10.3727/000000006781510705

Gene expression analysis in myotonic dystrophy : Indications for a common molecular pathogenic pathway in DM1 and DM2. / Botta, Annalisa; Vallo, Laura; Rinaldi, Fabrizio; Bonifazi, Emanuela; Amati, Francesca; Biancolella, Michela; Gambardella, Stefano; Mancinelli, Enzo; Angelini, Corrado; Meola, Giovanni; Novelli, Giuseppe.

In: Gene Expression, Vol. 13, No. 6, 2007, p. 339-351.

Research output: Contribution to journalArticle

Botta, A, Vallo, L, Rinaldi, F, Bonifazi, E, Amati, F, Biancolella, M, Gambardella, S, Mancinelli, E, Angelini, C, Meola, G & Novelli, G 2007, 'Gene expression analysis in myotonic dystrophy: Indications for a common molecular pathogenic pathway in DM1 and DM2', Gene Expression, vol. 13, no. 6, pp. 339-351. https://doi.org/10.3727/000000006781510705
Botta, Annalisa ; Vallo, Laura ; Rinaldi, Fabrizio ; Bonifazi, Emanuela ; Amati, Francesca ; Biancolella, Michela ; Gambardella, Stefano ; Mancinelli, Enzo ; Angelini, Corrado ; Meola, Giovanni ; Novelli, Giuseppe. / Gene expression analysis in myotonic dystrophy : Indications for a common molecular pathogenic pathway in DM1 and DM2. In: Gene Expression. 2007 ; Vol. 13, No. 6. pp. 339-351.
@article{2b9421793b2a426da18c81a4481b12c4,
title = "Gene expression analysis in myotonic dystrophy: Indications for a common molecular pathogenic pathway in DM1 and DM2",
abstract = "An RNA gain-of-function of expanded transcripts is the most accredited molecular mechanism for myotonic dystrophy type 1 (DM1) and 2 (DM2). To disclose molecular parallels and divergences in pathogenesis of both disorders, we compared the expression profile of muscle biopsies from DM1 and DM2 patients to controls. DM muscle tissues showed a reduction in the major skeletal muscle chloride channel (CLCN1) and transcription factor Sp1 transcript levels and an abnormal processing of the CLCN1 and insulin receptor (IR) pre-mRNAs. No essential differences were observed in the muscle blind-like gene (MBNL1) and CUG binding protein 1 (CUGBP1) transcript levels as well as in the splicing pattern of the myotubularin-related 1 (MTMR1) gene. Macroarray analysis of 96 neuroscience-related genes revealed a considerable similar expression profile between the DM samples, reflective of a common muscle pathology origin. Using a twofold threshold, we found six misregulated genes important in calcium and potassium metabolism and in mitochondrial functions. Our results indicate that the DM1 and DM2 overlapping clinical phenotypes may derive from a common trans acting mechanism that traps and influences shared genes and proteins.",
keywords = "Expression analysis, Ion channels, Myotonic dystrophy, Pathogenesis, Splicing",
author = "Annalisa Botta and Laura Vallo and Fabrizio Rinaldi and Emanuela Bonifazi and Francesca Amati and Michela Biancolella and Stefano Gambardella and Enzo Mancinelli and Corrado Angelini and Giovanni Meola and Giuseppe Novelli",
year = "2007",
doi = "10.3727/000000006781510705",
language = "English",
volume = "13",
pages = "339--351",
journal = "Gene Expression",
issn = "1052-2166",
publisher = "Cognizant Communication Corporation",
number = "6",

}

TY - JOUR

T1 - Gene expression analysis in myotonic dystrophy

T2 - Indications for a common molecular pathogenic pathway in DM1 and DM2

AU - Botta, Annalisa

AU - Vallo, Laura

AU - Rinaldi, Fabrizio

AU - Bonifazi, Emanuela

AU - Amati, Francesca

AU - Biancolella, Michela

AU - Gambardella, Stefano

AU - Mancinelli, Enzo

AU - Angelini, Corrado

AU - Meola, Giovanni

AU - Novelli, Giuseppe

PY - 2007

Y1 - 2007

N2 - An RNA gain-of-function of expanded transcripts is the most accredited molecular mechanism for myotonic dystrophy type 1 (DM1) and 2 (DM2). To disclose molecular parallels and divergences in pathogenesis of both disorders, we compared the expression profile of muscle biopsies from DM1 and DM2 patients to controls. DM muscle tissues showed a reduction in the major skeletal muscle chloride channel (CLCN1) and transcription factor Sp1 transcript levels and an abnormal processing of the CLCN1 and insulin receptor (IR) pre-mRNAs. No essential differences were observed in the muscle blind-like gene (MBNL1) and CUG binding protein 1 (CUGBP1) transcript levels as well as in the splicing pattern of the myotubularin-related 1 (MTMR1) gene. Macroarray analysis of 96 neuroscience-related genes revealed a considerable similar expression profile between the DM samples, reflective of a common muscle pathology origin. Using a twofold threshold, we found six misregulated genes important in calcium and potassium metabolism and in mitochondrial functions. Our results indicate that the DM1 and DM2 overlapping clinical phenotypes may derive from a common trans acting mechanism that traps and influences shared genes and proteins.

AB - An RNA gain-of-function of expanded transcripts is the most accredited molecular mechanism for myotonic dystrophy type 1 (DM1) and 2 (DM2). To disclose molecular parallels and divergences in pathogenesis of both disorders, we compared the expression profile of muscle biopsies from DM1 and DM2 patients to controls. DM muscle tissues showed a reduction in the major skeletal muscle chloride channel (CLCN1) and transcription factor Sp1 transcript levels and an abnormal processing of the CLCN1 and insulin receptor (IR) pre-mRNAs. No essential differences were observed in the muscle blind-like gene (MBNL1) and CUG binding protein 1 (CUGBP1) transcript levels as well as in the splicing pattern of the myotubularin-related 1 (MTMR1) gene. Macroarray analysis of 96 neuroscience-related genes revealed a considerable similar expression profile between the DM samples, reflective of a common muscle pathology origin. Using a twofold threshold, we found six misregulated genes important in calcium and potassium metabolism and in mitochondrial functions. Our results indicate that the DM1 and DM2 overlapping clinical phenotypes may derive from a common trans acting mechanism that traps and influences shared genes and proteins.

KW - Expression analysis

KW - Ion channels

KW - Myotonic dystrophy

KW - Pathogenesis

KW - Splicing

UR - http://www.scopus.com/inward/record.url?scp=34548072824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548072824&partnerID=8YFLogxK

U2 - 10.3727/000000006781510705

DO - 10.3727/000000006781510705

M3 - Article

C2 - 17708420

AN - SCOPUS:34548072824

VL - 13

SP - 339

EP - 351

JO - Gene Expression

JF - Gene Expression

SN - 1052-2166

IS - 6

ER -